BE1006829A3 - Compositions pharmaceutiques solides. - Google Patents

Compositions pharmaceutiques solides. Download PDF

Info

Publication number
BE1006829A3
BE1006829A3 BE9100683A BE9100683A BE1006829A3 BE 1006829 A3 BE1006829 A3 BE 1006829A3 BE 9100683 A BE9100683 A BE 9100683A BE 9100683 A BE9100683 A BE 9100683A BE 1006829 A3 BE1006829 A3 BE 1006829A3
Authority
BE
Belgium
Prior art keywords
sep
weight
chlorophyll
capsule
nifedipine
Prior art date
Application number
BE9100683A
Other languages
English (en)
French (fr)
Inventor
Margit Nee Kricsfalussy Nagy
Rita Balazs
Judit Marcisz
Katalin Nee Nagy Wagner
Eva Judit Nee Juhasz Tajthy
Attila Mandi
Margit Csoergo
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of BE1006829A3 publication Critical patent/BE1006829A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE9100683A 1990-07-20 1991-07-19 Compositions pharmaceutiques solides. BE1006829A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU904564A HUT59592A (en) 1990-07-20 1990-07-20 Process for the preparation of solid medical products

Publications (1)

Publication Number Publication Date
BE1006829A3 true BE1006829A3 (fr) 1995-01-03

Family

ID=10968329

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9100683A BE1006829A3 (fr) 1990-07-20 1991-07-19 Compositions pharmaceutiques solides.

Country Status (22)

Country Link
JP (1) JPH04253924A (el)
KR (1) KR920002162A (el)
BE (1) BE1006829A3 (el)
CA (1) CA2047482A1 (el)
CH (1) CH681960A5 (el)
CY (1) CY1840A (el)
CZ (1) CZ280064B6 (el)
DE (1) DE4124081A1 (el)
DK (1) DK137591A (el)
ES (1) ES2039177B1 (el)
FI (1) FI913493A (el)
FR (1) FR2664814B1 (el)
GB (1) GB2246072B (el)
GR (1) GR1002175B (el)
HU (1) HUT59592A (el)
IL (1) IL98894A0 (el)
IT (1) IT1250681B (el)
NL (1) NL9101268A (el)
SE (1) SE9102160L (el)
TW (1) TW203012B (el)
YU (1) YU47573B (el)
ZA (1) ZA915677B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411115D0 (en) * 1994-06-03 1994-07-27 Secr Defence Stabilisation of photosensitive material
WO1996033701A1 (en) * 1995-04-24 1996-10-31 Pfizer Inc. Inhibiting photodecomposition of 3-substituted-2-oxindoles
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
JP3549522B1 (ja) * 2003-10-24 2004-08-04 日清ファルマ株式会社 コエンザイムｑ１０含有カプセル剤
US9072791B2 (en) 2008-09-30 2015-07-07 Denki Kagaku Kogyo Kabushiki Kaisha Photostabilized pharmaceutical compositions
CA2968861C (en) 2017-05-30 2022-10-11 University Of Saskatchewan Topical nifedipine formulations and uses thereof
KR200489660Y1 (ko) * 2018-02-09 2019-07-19 김순희 퍼팅연습기

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451934A1 (fr) * 1979-03-23 1980-10-17 Chugai Pharmaceutical Co Ltd Revetement de gelatine coloree
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
EP0143857A1 (de) * 1983-11-30 1985-06-12 Siegfried Aktiengesellschaft Coronartherapeutikum in Form von Weichgelatine-Kapseln
WO1987000429A1 (en) * 1985-07-25 1987-01-29 Deutsche Gelatine-Fabriken Stoess & Co. Gmbh Opaque light-stable and possibly coloured gelatine products and method for their production
EP0221277A2 (de) * 1985-09-10 1987-05-13 Bayer Ag Beta-Carotin enthaltende Gelatine
EP0272336A1 (de) * 1986-12-18 1988-06-29 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6043046B2 (ja) * 1979-04-24 1985-09-26 パ−ク・デ−ビス・エンド・コンパニ− ゼラチンカプセル
JPS61225109A (ja) * 1985-03-29 1986-10-06 Shiseido Co Ltd カラメル含有組成物
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
JPS63215641A (ja) * 1987-03-05 1988-09-08 Toyo Jozo Co Ltd ゼラチン皮膜組成物
JPH01218573A (ja) * 1988-02-25 1989-08-31 Yoshio Tanaka ドナリエラ藻体含有固形状食品の製造法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451934A1 (fr) * 1979-03-23 1980-10-17 Chugai Pharmaceutical Co Ltd Revetement de gelatine coloree
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
EP0143857A1 (de) * 1983-11-30 1985-06-12 Siegfried Aktiengesellschaft Coronartherapeutikum in Form von Weichgelatine-Kapseln
WO1987000429A1 (en) * 1985-07-25 1987-01-29 Deutsche Gelatine-Fabriken Stoess & Co. Gmbh Opaque light-stable and possibly coloured gelatine products and method for their production
EP0221277A2 (de) * 1985-09-10 1987-05-13 Bayer Ag Beta-Carotin enthaltende Gelatine
EP0272336A1 (de) * 1986-12-18 1988-06-29 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPIL Section Ch, Week 8108, 17 Décembre 1980 Derwent Publications Ltd., London, GB; Class B04, AN 81-12795D & JP-A-55 161 863 (PARKE DAVIS & CO) *

Also Published As

Publication number Publication date
JPH04253924A (ja) 1992-09-09
KR920002162A (ko) 1992-02-28
DK137591A (da) 1992-01-21
HU904564D0 (en) 1990-12-28
CH681960A5 (el) 1993-06-30
ITMI912002A1 (it) 1993-01-19
FR2664814A1 (fr) 1992-01-24
FI913493A0 (fi) 1991-07-19
GR1002175B (en) 1996-03-07
ES2039177A1 (es) 1993-09-01
DK137591D0 (da) 1991-07-19
HUT59592A (en) 1992-06-29
ITMI912002A0 (it) 1991-07-19
ZA915677B (en) 1993-03-31
YU47573B (sh) 1995-10-03
GB9115693D0 (en) 1991-09-04
CS222291A3 (en) 1992-02-19
IT1250681B (it) 1995-04-21
GR910100319A (el) 1992-08-26
GB2246072B (en) 1994-06-15
FR2664814B1 (fr) 1995-05-24
SE9102160D0 (sv) 1991-07-10
YU127191A (sh) 1994-05-10
CA2047482A1 (en) 1992-01-21
DE4124081A1 (de) 1992-01-23
IL98894A0 (en) 1992-07-15
SE9102160L (sv) 1992-01-21
CY1840A (en) 1996-03-08
TW203012B (el) 1993-04-01
ES2039177B1 (es) 1994-03-16
NL9101268A (nl) 1992-02-17
FI913493A (fi) 1992-01-21
GB2246072A (en) 1992-01-22
CZ280064B6 (cs) 1995-10-18

Similar Documents

Publication Publication Date Title
EP0608207B1 (fr) Compositions pharmaceutiques contenant des nanocapsules
EP1032374B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques
EP0862423B1 (fr) Composition pharmaceutique pour administration par voie orale
CH678273A5 (el)
EP0830129B1 (fr) Compositions solides contenant du polyethyleneoxyde et un principe actif non amorphe
FR2565822A1 (fr) Nouvelle forme galenique retard
BE1006829A3 (fr) Compositions pharmaceutiques solides.
EP1401397B1 (fr) Formulation pharmaceutique au gout masque et son procede de preparation
EP0868184B1 (fr) Microgranules a liberation prolongee contenant du diltiazem comme principe actif
EP0927026A1 (fr) Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
WO1998024430A1 (fr) Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
FR2748209A1 (fr) Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs
BE1011413A4 (fr) Composition pharmaceutique pour abaisser la pression sanguine et son procede de preparation.
EP0356325B1 (fr) Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glycéride gélifié par au moins un polymère cellulosique
FR2467596A1 (fr) Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
WO2001066109A1 (fr) Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
EP0036345A1 (fr) Nouveau procédé d'enrobage d'au moins un principe actif médicamenteux, les nouveaux médicaments ainsi obtenus, et les compositions les renfermant
LU87777A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite
FR2656303A1 (fr) Solution buvable d'un derive des benzodiazepines et son application pharmacologique.
CA2182024C (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
FR2750859A1 (fr) Composition pharmaceutique destinee a une administration par voie buccale avec absorption d'au moins un principe actif a travers les muqueuses de la bouche
BE563436A (el)
CA2170844A1 (fr) Compositions pharmaceutiques comprenant des derives de dinoreburnamenine
OA10057A (fr) Compositions anti-paludeennes synergiques renfermant du benflumetol
CZ20001526A3 (cs) Farmaceuticky aktivní formulace obsahující artemisinin a/nebo deriváty artemisininu

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EGIS GYOGYSZERGYAR

Effective date: 19960731